
    
      Tazemetostat 800 mg BID is administered daily starting on Cycle 1 Day 1. Rituximab will be
      administered by either subcutaneous injection or IV infusion according to the regional
      product prescribing information and labeling. Rituximab will be administered at a dose of 375
      mg/m2 on Day 1, 8, 15, and 22 of Cycle 1, and then on Day 1 of Cycles 3 through 6, accounting
      for an additional 4 doses, i.e., a total of 8 doses of rituximab in 6 cycles.
    
  